660 related articles for article (PubMed ID: 8195718)
1. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
Selin LK; Nahill SR; Welsh RM
J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
[TBL] [Abstract][Full Text] [Related]
2. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.
Selin LK; Vergilis K; Welsh RM; Nahill SR
J Exp Med; 1996 Jun; 183(6):2489-99. PubMed ID: 8676069
[TBL] [Abstract][Full Text] [Related]
3. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
Nahill SR; Welsh RM
J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
[TBL] [Abstract][Full Text] [Related]
4. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
Walker CM; Paetkau V; Rawls WE; Rosenthal KL
J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
[TBL] [Abstract][Full Text] [Related]
6. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
Yang HY; Dundon PL; Nahill SR; Welsh RM
J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
[TBL] [Abstract][Full Text] [Related]
7. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
8. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations.
Selin LK; Varga SM; Wong IC; Welsh RM
J Exp Med; 1998 Nov; 188(9):1705-15. PubMed ID: 9802982
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
10. Private specificities of CD8 T cell responses control patterns of heterologous immunity.
Kim SK; Cornberg M; Wang XZ; Chen HD; Selin LK; Welsh RM
J Exp Med; 2005 Feb; 201(4):523-33. PubMed ID: 15710651
[TBL] [Abstract][Full Text] [Related]
11. CD8 T cell memory in B cell-deficient mice.
Asano MS; Ahmed R
J Exp Med; 1996 May; 183(5):2165-74. PubMed ID: 8642326
[TBL] [Abstract][Full Text] [Related]
12. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.
Oehen S; Waldner H; Kündig TM; Hengartner H; Zinkernagel RM
J Exp Med; 1992 Nov; 176(5):1273-81. PubMed ID: 1402673
[TBL] [Abstract][Full Text] [Related]
13. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation.
Kim SK; Brehm MA; Welsh RM; Selin LK
J Immunol; 2002 Jul; 169(1):90-8. PubMed ID: 12077233
[TBL] [Abstract][Full Text] [Related]
15. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.
Borrow P; Tishon A; Oldstone MB
J Exp Med; 1991 Jul; 174(1):203-12. PubMed ID: 1905339
[TBL] [Abstract][Full Text] [Related]
16. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.
von Herrath MG; Yokoyama M; Dockter J; Oldstone MB; Whitton JL
J Virol; 1996 Feb; 70(2):1072-9. PubMed ID: 8551565
[TBL] [Abstract][Full Text] [Related]
17. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus.
Whitton JL; Gebhard JR; Lewicki H; Tishon A; Oldstone MB
J Virol; 1988 Mar; 62(3):687-95. PubMed ID: 2448497
[TBL] [Abstract][Full Text] [Related]
18. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus.
Moskophidis D; Zinkernagel RM
J Virol; 1995 Apr; 69(4):2187-93. PubMed ID: 7533851
[TBL] [Abstract][Full Text] [Related]
19. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
20. Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains.
Ahmed R; Byrne JA; Oldstone MB
J Virol; 1984 Jul; 51(1):34-41. PubMed ID: 6610062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
